Sight Sciences, Inc. Common Stock (SGHT) Stock Price

SGHTStock

$8.28+140.00%52W

Market Cap$456.13M

P/E—

PEG Ratio—

Div yield—

Beta2.46

SGHT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)106.85%

Price vs S&P 500 (4W)-1.15%

VGM Score60.84

Book Value / Share (Quarterly)$0.97

P/TBV (Annual)0.94x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.74%

Cash Flow / Share (Quarterly)$-0.43

Price vs S&P 500 (YTD)-7.51%

Gross Margin (TTM)88.44%

Net Profit Margin (TTM)-35.69%

EPS (TTM)$-0.56

10-Day Avg Trading Volume0.35M

EPS Excl Extra (TTM)$-0.56

Revenue Growth (5Y)22.86%

EPS (Annual)$-0.74

ROI (Annual)-36.86%

Gross Margin (Annual)86.95%

Net Profit Margin (5Y Avg)-86.44%

Cash / Share (Quarterly)$1.46

Revenue Growth QoQ (YoY)19.55%

ROA (Last FY)-33.33%

Revenue Growth TTM (YoY)9.27%

EBITD / Share (TTM)$-0.51

ROE (5Y Avg)-49.23%

Operating Margin (TTM)-33.43%

Cash Flow / Share (Annual)$-0.56

P/B Ratio8.62x

P/B Ratio (Quarterly)5.58x

Net Income / Employee (Annual)$-206,600

EV / Revenue (TTM)5.00x

Net Interest Coverage (TTM)-31.86x

ROA (TTM)-26.68%

EPS Incl Extra (Annual)$-0.74

Current Ratio (Annual)10.22x

Quick Ratio (Quarterly)4.45x

3-Month Avg Trading Volume0.25M

52-Week Price Return140.00%

Revenue / Employee (TTM)$448,300

Tangible BV / Share (Quarterly)$2.61

P/S Ratio (Annual)5.90x

Asset Turnover (Annual)0.67x

52-Week High$9.71

Operating Margin (5Y Avg)-81.44%

EPS Excl Extra (Annual)$-0.74

CapEx CAGR (5Y)-25.10%

26-Week Price Return116.75%

Quick Ratio (Annual)9.22x

13-Week Price Return64.61%

Total Debt / Equity (Annual)0.63x

Current Ratio (Quarterly)4.95x

Enterprise Value$417.15M

Revenue / Share Growth (5Y)19.32%

Asset Turnover (TTM)0.75x

Revenue / Employee (Annual)$415,900

Inventory Turnover (Annual)1.43x

Pretax Margin (Annual)-49.66%

Cash / Share (Annual)$1.72

3-Month Return Std Dev72.46%

Gross Margin (5Y Avg)84.57%

Net Income / Employee (TTM)$-160,000

ROE (Last FY)-60.10%

Net Interest Coverage (Annual)-14.39x

EPS Basic Excl Extra (Annual)$-0.74

Receivables Turnover (TTM)7.94x

Total Debt / Equity (Quarterly)0.77x

EPS Incl Extra (TTM)$-0.56

Receivables Turnover (Annual)7.54x

ROI (TTM)-30.00%

P/S Ratio (TTM)5.47x

Pretax Margin (5Y Avg)-86.26%

Revenue / Share (Annual)$1.48

Tangible BV / Share (Annual)$3.31

Price vs S&P 500 (52W)124.47%

Year-to-Date Return4.41%

5-Day Price Return-7.64%

EPS Normalized (Annual)$-0.74

ROA (5Y Avg)-33.13%

Net Profit Margin (Annual)-49.67%

Month-to-Date Return-11.54%

Cash Flow / Share (TTM)$-1.26

EBITD / Share (Annual)$-0.70

Operating Margin (Annual)-47.95%

LT Debt / Equity (Annual)0.63x

ROI (5Y Avg)-36.37%

LT Debt / Equity (Quarterly)0.58x

EPS Basic Excl Extra (TTM)$-0.56

P/TBV (Quarterly)1.19x

P/B Ratio (Annual)6.56x

Inventory Turnover (TTM)1.62x

Pretax Margin (TTM)-35.73%

Book Value / Share (Annual)$1.20

Price vs S&P 500 (13W)61.93%

Beta2.46x

Revenue / Share (TTM)$1.53

ROE (TTM)-50.64%

52-Week Low$3.37

vGradeD

gGradeB

mGradeA

vgmGradeB

SGHT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.14	-$0.08	+42.85%(+$0.06)
Q1 2026	May 6, 2026	-$0.20	-$0.24	-18.03%(-$0.04)
Q4 2025	Mar 4, 2026	-$0.14	-$0.08	+42.90%(+$0.06)
Q3 2025	Nov 6, 2025	-$0.26	-$0.16	+38.61%(+$0.10)
Q2 2025	Aug 7, 2025	-$0.28	-$0.23	+16.87%(+$0.05)

SGHT Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Sight Sciences, Inc. Common Stock

Sight Sciences develops surgical and nonsurgical medical devices for treating eye diseases. The company's lead product, the OMNI Surgical System, treats primary open-angle glaucoma through minimally invasive canaloplasty and trabeculotomy using a single corneal incision. The company also markets the TearCare System for dry eye treatment, with glaucoma products generating the majority of revenue.

SGHT Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.13

Revenue estimate$23.55M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

SGHT Insider Transactions

SellOct 2, 2026
BAUERLEIN ALISON
Chief Operating Officer
Shares: 25,260Value: $223,627
SellOct 2, 2026
RODBERG JAMES
Chief Financial Officer
Shares: 7,208Value: $63,812
SellOct 2, 2026
TAYLOR BRENTON
Officer
Shares: 2,988Value: $26,453
SellOct 1, 2026
BADAWI PAUL
Chief Executive Officer
Shares: 29,653Value: $268,330
SellOct 1, 2026
BADAWI DAVID
Chief Technology Officer
Shares: 7,797Value: $70,555

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for October 2026

Companies in Related Industries

CTKBCytek Biosciences, Inc. Common StockLab Analytical Instruments
AVRAnteris Technologies Global Corp. Common StockOrthopedic & Prosthetic Devices
PACBPacific Biosciences of California, Inc.Lab Analytical Instruments
MASS908 Devices Inc. Common StockLab Analytical Instruments
SENSSenseonics Holdings, Inc. Common StockIndustrial Instruments
FOSLFossil Group, Inc.Watches & Clocks
PREPrenetics Global Limited Class A Ordinary ShareLab Analytical Instruments
CVCapsoVision, Inc. Common StockElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.0

Buy

Consensus rating

52-Week Range

Low$3.37

High$9.71